Organigram Holdings Inc. (TSE:OGI – Free Report) – Research analysts at Atb Cap Markets issued their Q4 2025 EPS estimates for Organigram in a report released on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings of ($0.01) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share.
A number of other research analysts have also commented on OGI. Canaccord Genuity Group reduced their price target on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a research report on Monday, December 9th. ATB Capital dropped their price objective on shares of Organigram from C$5.25 to C$3.50 in a report on Tuesday.
Organigram Stock Up 6.2 %
Organigram stock opened at C$2.22 on Friday. The firm has a 50 day simple moving average of C$2.26 and a 200 day simple moving average of C$2.30. The firm has a market capitalization of C$241.03 million, a price-to-earnings ratio of -0.88, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. Organigram has a 1-year low of C$1.61 and a 1-year high of C$3.95.
Insider Activity at Organigram
In related news, Senior Officer Paolo De Luca sold 12,014 shares of the company’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is currently owned by corporate insiders.
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Further Reading
- Five stocks we like better than Organigram
- Transportation Stocks Investing
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Using the MarketBeat Dividend Yield Calculator
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What is the Nasdaq? Complete Overview with History
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.